Tetracyclines in dentistry are used for aggressive periodontitis in conjunction with root surface debridement

Prepare for the UCP2.04 Bad Blood Test with engaging quizzes. Access flashcards, multiple choice questions, and detailed explanations. Master every topic and get ready to pass with confidence!

Multiple Choice

Tetracyclines in dentistry are used for aggressive periodontitis in conjunction with root surface debridement

Explanation:
Tetracyclines are chosen as an adjunct to root surface debridement in aggressive periodontitis because they address both the microbial cause and the tissue-destructive host response. Aggressive periodontitis is driven by virulent bacteria, such as Aggregatibacter actinomycetemcomitans, that rapidly invade and damage supporting structures. Tetracyclines have strong activity against these pathogens and can be delivered systemically or locally, providing high concentrations in the pocket when used with mechanical debridement. Beyond killing bacteria, they inhibit host enzymes like matrix metalloproteinases that degrade collagen in periodontal tissues, helping to limit tissue destruction. The antibiotics also tend to persist in the periodontal environment (substantivity), so residual bacteria after debridement are suppressed over time. When root surface debridement is combined with tetracycline therapy, clinical outcomes improve compared with debridement alone because you’re both removing biofilm mechanically and reducing the infection and inflammatory processes more effectively. This approach isn’t used for acute caries treatment, isn’t indicated for end-stage periodontal disease without debridement, and isn’t applied as a stand-alone extraction-planning strategy.

Tetracyclines are chosen as an adjunct to root surface debridement in aggressive periodontitis because they address both the microbial cause and the tissue-destructive host response. Aggressive periodontitis is driven by virulent bacteria, such as Aggregatibacter actinomycetemcomitans, that rapidly invade and damage supporting structures. Tetracyclines have strong activity against these pathogens and can be delivered systemically or locally, providing high concentrations in the pocket when used with mechanical debridement.

Beyond killing bacteria, they inhibit host enzymes like matrix metalloproteinases that degrade collagen in periodontal tissues, helping to limit tissue destruction. The antibiotics also tend to persist in the periodontal environment (substantivity), so residual bacteria after debridement are suppressed over time. When root surface debridement is combined with tetracycline therapy, clinical outcomes improve compared with debridement alone because you’re both removing biofilm mechanically and reducing the infection and inflammatory processes more effectively.

This approach isn’t used for acute caries treatment, isn’t indicated for end-stage periodontal disease without debridement, and isn’t applied as a stand-alone extraction-planning strategy.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy